Relationship between long-acting reversible contraception and acne in a cohort of adolescents and young adults

被引:1
|
作者
Boos, Markus D. [1 ,2 ,8 ]
Ryan, Morgan E. [3 ]
Milliren, Carly [3 ]
Golub, Sarah [4 ]
Maslyanskaya, Sofya [5 ]
Escovedo, Michelle [6 ]
Divasta, Amy [7 ]
Pitts, Sarah [7 ]
机构
[1] Univ Washington, Sch Med, Dept Pediat, Div Dermatol, Seattle, WA USA
[2] Seattle Childrens Hosp, Seattle, WA USA
[3] Boston Childrens Hosp, Inst Ctr Clin & Translat Res, Boston, MA USA
[4] Univ Washington, Seattle Childrens Hosp, Sch Med, Dept Pediat, Seattle, WA USA
[5] Childrens Hosp Montefiore, Div Adolescent Med, New York, NY USA
[6] Childrens Hosp Los Angeles, Div Adolescent Young Adult Med, Los Angeles, CA USA
[7] Boston Childrens Hosp, Div Adolescent Young Adult Med, Boston, MA USA
[8] Seattle Childrens Hosp, Dept Surg, 4800 Sand Point Way NE,OC9 833, Seattle, WA 98105 USA
关键词
acne; adolescence; long-acting reversible contraception; progestin;
D O I
10.1111/pde.15578
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
BackgroundThe use of progestin-only long-acting reversible contraception (LARC) may be a risk factor for acne. Few studies have focused primarily on the effects of hormonal LARC on the development or exacerbation of acne in adolescents and young adults. We sought to understand the incidence and management of acne following hormonal LARC insertion in this adolescent/young adult population.MethodsA secondary data analysis was conducted of prospectively collected quality improvement (QI) data from the Adolescent Medicine LARC Collaborative. Subjects were evaluated by clinicians in adolescent medicine clinics at participating study sites, and acne severity was documented using a standardized recording instrument and scale. Descriptive statistics were reported as frequencies and percentages for categorical variables or mean and standard deviation (SD) for continuous variables. We compared demographic and clinical characteristics by those who had worsening acne, accounting for site inter-correlation using Cochran-Mantel-Haenszel chi-square tests for categorical variables and linear generalized estimating equation (GEE) regression for continuous variables.ResultsOf 1319 subjects who completed LARC insertion, 28.5% (376/1319) experienced worsening acne following use of progestin-only LARC. Acne was a contributing factor to LARC removal in only 3% (40/1319), and the sole reason for removal in 0.4% (5/1319) of all subjects. As this was a secondary analysis of prospectively collected QI data, limitations of this study include incomplete or inaccurate documentation of acne severity. Moreover, LARC insertions without follow-up/removal visits or with only follow-up/removal within 8 weeks of insertion were excluded from our study, which may also bias results.ConclusionsAdolescents and young adults seeking progestin-only LARC should be counseled about the potential for developing acne or experiencing a worsening of existing acne during LARC use. However, acne was not a common reason for LARC discontinuation.
引用
收藏
页码:628 / 634
页数:7
相关论文
共 50 条
  • [41] A Qualitative Analysis of Long-Acting Reversible Contraception
    Sundstrom, Beth
    Baker-Whitcomb, Annalise
    DeMaria, Andrea L.
    MATERNAL AND CHILD HEALTH JOURNAL, 2015, 19 (07) : 1507 - 1514
  • [42] A Qualitative Analysis of Long-Acting Reversible Contraception
    Beth Sundstrom
    Annalise Baker-Whitcomb
    Andrea L. DeMaria
    Maternal and Child Health Journal, 2015, 19 : 1507 - 1514
  • [43] Efficacy and Safety of Long-Acting Reversible Contraception
    Stoddard, Amy
    McNicholas, Colleen
    Peipert, Jeffrey F.
    DRUGS, 2011, 71 (08) : 969 - 980
  • [44] Immediate Postpartum Long-Acting Reversible Contraception
    Borders, Ann E.
    Stuebe, Alison M.
    OBSTETRICS AND GYNECOLOGY, 2016, 128 (02): : E32 - E37
  • [45] New Addition to Long-Acting Reversible Contraception
    Raphaelidis, Leia
    JNP-JOURNAL FOR NURSE PRACTITIONERS, 2015, 11 (03): : 377 - 378
  • [46] Efficacy and Safety of Long-Acting Reversible Contraception
    Amy Stoddard
    Colleen McNicholas
    Jeffrey F. Peipert
    Drugs, 2011, 71 : 969 - 980
  • [47] Trends in Continuation of Long-Acting Reversible Contraception Among Adolescents Receiving Medicaid
    Allison, Bianca A.
    Ritter, Victor
    Lin, Feng-Chang
    Flower, Kori B.
    Perry, Martha F.
    JOURNAL OF ADOLESCENT HEALTH, 2024, 75 (03) : 487 - 495
  • [48] Impact of the Rochester LARC Initiative on adolescents' utilization of long-acting reversible contraception
    Aligne, C. Andrew
    Phelps, Rachael
    VanScott, Jessica L.
    Korones, Sarah A.
    Greenberg, Katherine B.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2020, 222 (04)
  • [49] An educational video on long-acting reversible contraception as a counseling tool for postpartum adolescents
    Santibenchakul, Somsook
    Thanativakul, Kittithorn
    Jaisamrarn, Unnop
    CONTRACEPTION AND REPRODUCTIVE MEDICINE, 2022, 7 (01)
  • [50] Long-Acting Reversible Contraception Counseling and Use for Older Adolescents and Nulliparous Women
    Gibbs, Susannah E.
    Rocca, Corinne H.
    Bednarek, Paula
    Thompson, Kirsten M. J.
    Darney, Philip D.
    Harper, Cynthia C.
    JOURNAL OF ADOLESCENT HEALTH, 2016, 59 (06) : 703 - 709